Page
%P
-
Article
Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
High-dose melphalan (HDM) is an essential component in the treatment of patients with multiple myeloma (MM). Few data are available regarding genetic polymorphisms associated with patient outcome or toxicity i...